| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |